Q9NSA0 (S22AB_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
April 3, 2013.
Version 92.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Solute carrier family 22 member 11 Alternative name(s): Organic anion transporter 4 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 550 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Mediates saturable uptake of estrone sulfate, dehydroepiandrosterone sulfate and related compounds. Ref.1 Ref.7 Ref.8 |
| Subcellular location | |
| Tissue specificity | Detected in placenta and kidney. Ref.1 |
| Post-translational modification | N-glycosylated. Contains several complex-type N-glycans. Ref.9 |
| Sequence similarities | Belongs to the major facilitator (TC 2.A.1) superfamily. Organic cation transporter (TC 2.A.1.19) family. [View classification] |
| Sequence caution | The sequence BAC11483.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Ion transport Transport |
| Cellular component | Cell membrane Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Transmembrane Transmembrane helix |
| PTM | Glycoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | urate metabolic process Inferred from mutant phenotype PubMed 19503597. Source: BHF-UCL |
| Cellular_component | apical plasma membrane Inferred from direct assay PubMed 15037815. Source: UniProtKB external side of plasma membraneInferred from direct assay Ref.8. Source: UniProtKB integral to plasma membraneInferred from direct assay Ref.1. Source: UniProtKB |
| Molecular_function | inorganic anion exchanger activity Inferred from direct assay PubMed 15037815. Source: UniProtKB sodium-independent organic anion transmembrane transporter activityInferred from direct assay Ref.1. Source: UniProtKB |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9NSA0-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9NSA0-2) The sequence of this isoform differs from the canonical sequence as follows: 353-461: NFSLLISYYG...KAELFPTPVR → K | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 550 | 550 | Solute carrier family 22 member 11 | PRO_0000234435 | |||||
Regions | |||||||||
| Topological domain | 1 – 10 | 10 | Cytoplasmic Potential | ||||||
| Transmembrane | 11 – 31 | 21 | Helical; Potential | ||||||
| Topological domain | 32 – 142 | 111 | Extracellular Potential | ||||||
| Transmembrane | 143 – 163 | 21 | Helical; Potential | ||||||
| Topological domain | 164 – 174 | 11 | Cytoplasmic Potential | ||||||
| Transmembrane | 175 – 195 | 21 | Helical; Potential | ||||||
| Topological domain | 196 – 200 | 5 | Extracellular Potential | ||||||
| Transmembrane | 201 – 221 | 21 | Helical; Potential | ||||||
| Topological domain | 222 – 231 | 10 | Cytoplasmic Potential | ||||||
| Transmembrane | 232 – 252 | 21 | Helical; Potential | ||||||
| Topological domain | 253 – 256 | 4 | Extracellular Potential | ||||||
| Transmembrane | 257 – 277 | 21 | Helical; Potential | ||||||
| Topological domain | 278 – 346 | 69 | Cytoplasmic Potential | ||||||
| Transmembrane | 347 – 367 | 21 | Helical; Potential | ||||||
| Topological domain | 368 – 378 | 11 | Extracellular Potential | ||||||
| Transmembrane | 379 – 399 | 21 | Helical; Potential | ||||||
| Topological domain | 400 – 402 | 3 | Cytoplasmic Potential | ||||||
| Transmembrane | 403 – 423 | 21 | Helical; Potential | ||||||
| Topological domain | 424 – 430 | 7 | Extracellular Potential | ||||||
| Transmembrane | 431 – 451 | 21 | Helical; Potential | ||||||
| Topological domain | 452 – 463 | 12 | Cytoplasmic Potential | ||||||
| Transmembrane | 464 – 484 | 21 | Helical; Potential | ||||||
| Topological domain | 485 – 490 | 6 | Extracellular Potential | ||||||
| Transmembrane | 491 – 511 | 21 | Helical; Potential | ||||||
| Topological domain | 512 – 550 | 39 | Cytoplasmic Potential | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 39 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 56 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 99 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Alternative sequence | 353 – 461 | 109 | NFSLL…PTPVR → K in isoform 2. | VSP_018319 | |||||
| Natural variant | 155 | 1 | V → G. Corresponds to variant rs12785832 [ dbSNP | Ensembl ]. | VAR_053962 | |||||
Experimental info | |||||||||
| Mutagenesis | 39 | 1 | N → Q: No visible effect on N-glycosylation. Loss of N-glycosylation and of cell surface location; when associated with Q-56; Q-63 and Q-99. Ref.9 | ||||||
| Mutagenesis | 47 | 1 | H → A: Reduced cell surface expression and estrone sulfate transport. Reduced cell surface expression and estrone sulfate transport; when associated with A-52; A-83; A-305 and A-469. Ref.7 | ||||||
| Mutagenesis | 52 | 1 | H → A: Slightly reduced estrone sulfate transport. Reduced cell surface expression and estrone sulfate transport; when associated with A-47; A-83; A-305 and A-469. Ref.7 | ||||||
| Mutagenesis | 56 | 1 | N → Q: No visible effect on N-glycosylation. Loss of N-glycosylation and of cell surface expression; when associated with Q-39; Q-63 and Q-99. Ref.9 | ||||||
| Mutagenesis | 63 | 1 | N → Q: No visible effect on N-glycosylation. Loss of N-glycosylation and of cell surface expression; when associated with Q-39; Q-56 and Q-99. Ref.9 | ||||||
| Mutagenesis | 83 | 1 | H → A: Reduced cell surface expression and estrone sulfate transport; when associated with A-47; A-52; A-305 and A-469. Ref.7 | ||||||
| Mutagenesis | 99 | 1 | N → Q: No visible effect on N-glycosylation. Loss of N-glycosylation and of cell surface expression; when associated with Q-39; Q-56 and Q-63. Ref.9 | ||||||
| Mutagenesis | 241 | 1 | G → L, S or V: Strongly reduced cell surface expression and estrone sulfate transport. Ref.8 | ||||||
| Mutagenesis | 305 | 1 | H → A: Reduced cell surface expression and estrone sulfate transport; when associated with A-47; A-52; A-83 and A-469. Ref.7 | ||||||
| Mutagenesis | 400 | 1 | G → L, S or V: Strongly reduced cell surface expression and estrone sulfate transport. Ref.8 | ||||||
| Mutagenesis | 469 | 1 | H → A: Slightly reduced estrone sulfate transport. Reduced cell surface expression and estrone sulfate transport; when associated with A-47; A-52; A-83 and A-305. Ref.7 | ||||||
| Sequence conflict | 180 | 1 | L → S in BAD96589. Ref.3 | ||||||
| Sequence conflict | 376 | 1 | L → R in BAC85252. Ref.2 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta." Cha S.H., Sekine T., Kusuhara H., Yu E., Kim J.Y., Kim D.K., Sugiyama Y., Kanai Y., Endou H. J. Biol. Chem. 275:4507-4512(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY. Tissue: Kidney. |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). Tissue: Kidney and Placenta. |
| [3] | Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S. Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Liver. |
| [4] | "Human chromosome 11 DNA sequence and analysis including novel gene identification." Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G. Sakaki Y.Nature 440:497-500(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Colon. |
| [7] | "Mutational analysis of histidine residues in human organic anion transporter 4 (hOAT4)." Zhou F., Pan Z., Ma J., You G. Biochem. J. 384:87-92(2004) [PubMed] [Europe PMC] [Abstract] Cited for: MUTAGENESIS OF HIS-47; HIS-52; HIS-83; HIS-305 AND HIS-469, FUNCTION, SUBCELLULAR LOCATION. |
| [8] | "The role of glycine residues in the function of human organic anion transporter 4." Zhou F., Tanaka K., Pan Z., Ma J., You G. Mol. Pharmacol. 65:1141-1147(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, MUTAGENESIS OF GLY-241 AND GLY-400. |
| [9] | "The role of N-linked glycosylation in protein folding, membrane targeting, and substrate binding of human organic anion transporter hOAT4." Zhou F., Xu W., Hong M., Pan Z., Sinko P.J., Ma J., You G. Mol. Pharmacol. 67:868-876(2005) [PubMed] [Europe PMC] [Abstract] Cited for: MUTAGENESIS OF ASN-39; ASN-56; ASN-63 AND ASN-99, SUBCELLULAR LOCATION, GLYCOSYLATION. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AB026116 mRNA. Translation: BAA95316.1. AK075224 mRNA. Translation: BAC11483.1. Different initiation. AK129930 mRNA. Translation: BAC85252.1. AK222869 mRNA. Translation: BAD96589.1. AK290791 mRNA. Translation: BAF83480.1. AC044790 Genomic DNA. Translation: AAK68155.1. CH471076 Genomic DNA. Translation: EAW74269.1. BC034384 mRNA. Translation: AAH34384.1. |
| IPI | IPI00020542. IPI00418660. |
| RefSeq | NP_060954.1. NM_018484.2. |
| UniGene | Hs.220844. |
3D structure databases | |
| ProteinModelPortal | Q9NSA0. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 9606.ENSP00000301891. |
Protein family/group databases | |
| TCDB | 2.A.1.19.10. major facilitator superfamily (MFS). |
Polymorphism databases | |
| DMDM | 74734337. |
Proteomic databases | |
| PaxDb | Q9NSA0. |
| PRIDE | Q9NSA0. |
Protocols and materials databases | |
| DNASU | 55867. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000301891; ENSP00000301891; ENSG00000168065. ENST00000377585; ENSP00000366809; ENSG00000168065. |
| GeneID | 55867. |
| KEGG | hsa:55867. |
| UCSC | uc001oai.3. human. uc009ypq.3. human. |
Organism-specific databases | |
| CTD | 55867. |
| GeneCards | GC11P064324. |
| HGNC | HGNC:18120. SLC22A11. |
| HPA | HPA026076. |
| MIM | 607097. gene. |
| neXtProt | NX_Q9NSA0. |
| PharmGKB | PA38295. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG0477. |
| HOGENOM | HOG000234569. |
| HOVERGEN | HBG108433. |
| InParanoid | Q9NSA0. |
| KO | K08207. |
| OMA | NPRHPME. |
| OrthoDB | EOG418BPG. |
| PhylomeDB | Q9NSA0. |
Enzyme and pathway databases | |
| Reactome | REACT_15518. Transmembrane transport of small molecules. |
Gene expression databases | |
| ArrayExpress | Q9NSA0. |
| Bgee | Q9NSA0. |
| CleanEx | HS_SLC22A11. |
| Genevestigator | Q9NSA0. |
| GermOnline | ENSG00000168065. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR020846. MFS_dom. IPR016196. MFS_dom_general_subst_transpt. IPR005828. Sub_transporter. [Graphical view] |
| Pfam | PF00083. Sugar_tr. 1 hit. [Graphical view] |
| SUPFAM | SSF103473. MFS_gen_substrate_transporter. 1 hit. |
| PROSITE | PS50850. MFS. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | SLC22A11. human. |
| DrugBank | DB01032. Probenecid. |
| GenomeRNAi | 55867. |
| NextBio | 61178. |
| SOURCE | Search... |
Entry information
| Entry name | S22AB_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9NSA0 Secondary accession number(s): A8K426 Q8NBU4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 11 Human chromosome 11: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
